The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

This new FDA-approved shot is designed to break down the barriers that have kept too many people from accessing PrEP.

Cuts to U.S. foreign aid will endanger HIV treatment and prevention services globally and are likely to reverse decades of ...

A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.

Six months of prevention -- that's how long Lenacapavir, the new drug for HIV prevention lasts.The Food and Drug Administration approved it last month, and desp ...

Strategies that address population-specific concerns about medical mistrust and employ operational tactics, including staff ...

The Department of Justice said it sent more than 20 subpoenas to doctors and clinics involved with transgender medical ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

COVID paused prevention efforts, which helped fuel the rise in new infections. Now federal funding cuts threaten to disrupt those efforts again.

Congress just passed a sweeping bill that includes changes to Medicaid expected to cut millions of people with low incomes ...